Results 21 to 30 of about 139,532 (214)

Noninvasive in vivo tracking of mesenchymal stem cells and evaluation of cell therapeutic effects in a murine model using a clinical 3.0 T MRI [PDF]

open access: yes, 2013
Cardiac cell therapy with mesenchymal stem cells (MSCs) represents a promising treatment approach for endstage heart failure. However, little is known about the underlying mechanisms and the fate of the transplanted cells. The objective of the presented
Bovenschulte, Henning   +11 more
core   +1 more source

Improvise the working condition at Kilang Beras Jelapang Selatan (M) Sdn. Bhd. [PDF]

open access: yes, 2020
Kilang Beras Jelapang Selatan (M) Sdn. Bhd. or known as KBJS was established on 11th March 1988. KBJS is located at industrial area, Batu 2 ¾ Jalan Salleh,8400, Muar, Johor. The size of the factory is more than 2.5 acre.
Mahmood, Salwa   +2 more
core   +1 more source

Secondary metabolites, antioxidant, and antiproliferative activities of Dioscorea bulbifera Leaf Collected from Endau Rompin, Johor, Malaysia [PDF]

open access: yes, 2021
Breast cancer is among the most commonly diagnosed cancer and the leading cause of cancer-related death among women globally. Malaysia is a country that is rich in medicinal plant species. Hence, this research aims to explore the secondary metabolites,
Abu Bakar, Fazleen Izzany   +5 more
core   +1 more source

Mesenchymal stem cells in transplantation and tissue regeneration [PDF]

open access: yesFrontiers in Immunology, 2011
Mesenchymal stem cells (MSC) were identified in the 1960s as bone marrow cells capable of osteogenic differentiation (Friedenstein and Petrakova, 1966). In the following decennia, these cells were further attributed with the capacity to differentiate into adipogenic, chondrogenic, and myogenic lineages (Pittenger et al., 1999), to secrete trophic ...
Hoogduijn, Martin J., Dor, Frank J.
openaire   +3 more sources

Mesenchymal stem cell-based therapy for ischemic stroke [PDF]

open access: yes, 2016
Ischemic stroke represents a major, worldwide health burden with increasing incidence. Patients affected by ischemic strokes currently have few clinically approved treatment options available.
Anderson, JD   +20 more
core   +2 more sources

12 hours after cerebral ischemia is the optimal time for bone marrow mesenchymal stem cell transplantation

open access: yesNeural Regeneration Research, 2015
Cell therapy using stem cell transplantation against cerebral ischemia has been reported. However, it remains controversial regarding the optimal time for cell transplantation and the transplantation route.
Seyed Mojtaba Hosseini   +4 more
doaj   +1 more source

Mesenchymal Stem Cell Transplantation for Neurodegenerative Diseases

open access: yesCell Transplantation, 2008
Neurodegenerative diseases are characterized by a progressive degeneration of selective neural populations. The lack of effective treatment and the characteristic of their pathology make these diseases appropriate candidates for cell therapy. Mesenchymal stem cells (MSCs) are multipotent stem-like cells that are capable of differentiating into ...
Y. Torrente, E. Polli
openaire   +4 more sources

Physiological conditions influencing regenerative potential of stem cells [PDF]

open access: yes, 2016
Stem cells are being used in the treatment of cardivovascular diseases. Here, we review the physiologic and pathologic conditions that impact the regenerative potential of stem cells in the treatment of cardiovascular diseases which include the influence
Avitabile, Daniele   +3 more
core   +1 more source

Mesenchymal stem cells in the treatment of ischemic stroke [PDF]

open access: yesКлиническая практика
Over the past two decades, multiple preclinical studies have shown that transplantation of mesenchymal stem cells leads to a pronounced positive effect in animals with experimental stroke.
Daria D. Namestnikova   +6 more
doaj   +1 more source

Umbilical Cord-Derived Mesenchymal Stem Cells for Hematopoietic Stem Cell Transplantation [PDF]

open access: yesJournal of Biomedicine and Biotechnology, 2012
Hematopoietic stem cell transplantation (HSCT) is becoming an effective therapeutic modality for a variety of diseases. Mesenchymal stem cells (MSCs) can be used to enhance hematopoietic engraftment, accelerate lymphocyte recovery, reduce the risk of graft failure, prevent and treat graft-versus-host disease, and repair tissue damage in patients ...
Chao, Yu-Hua   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy